Cash Flow Statement
Growth Metrics

Harte Hanks (HHS) Current Deferred Revenue (2016 - 2025)

Harte Hanks has reported Current Deferred Revenue over the past 16 years, most recently at $813000.0 for Q4 2025.

  • Quarterly Current Deferred Revenue fell 48.84% to $813000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $813000.0 through Dec 2025, down 48.84% year-over-year, with the annual reading at $813000.0 for FY2025, 48.84% down from the prior year.
  • Current Deferred Revenue was $813000.0 for Q4 2025 at Harte Hanks, down from $2.5 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $7.0 million in Q3 2022 and troughed at $813000.0 in Q4 2025.
  • The 5-year median for Current Deferred Revenue is $4.3 million (2021), against an average of $4.2 million.
  • Year-over-year, Current Deferred Revenue soared 41.51% in 2022 and then crashed 50.27% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $3.9 million in 2021, then increased by 16.44% to $4.6 million in 2022, then tumbled by 30.39% to $3.2 million in 2023, then crashed by 50.27% to $1.6 million in 2024, then tumbled by 48.84% to $813000.0 in 2025.
  • Per Business Quant, the three most recent readings for HHS's Current Deferred Revenue are $813000.0 (Q4 2025), $2.5 million (Q3 2025), and $1.8 million (Q2 2025).